2021 vaccines for adults
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75D30121D11354
- Awardee
-
Merck Sharp & Dohme LLC UEI FCFDA78HKKG2
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- 2021 Vaccines For Adults (VFA) Solicitation · 75D30121R71942 · Posted Apr 5, 2021
- 2021 Vaccines For Adults (VFA) Award Notice · Posted Jul 7, 2021
- Last date to order 100% complete
- IDV ceiling
- $83,485,760.00
- Maximum order
- $83,485,760.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Centers for Disease Control and Prevention awarded multiple indefinite delivery contracts to Merck Sharp & Dohme LLC for adult vaccines. The contracts have a potential value of $83,485,760 and a period of performance from July 1, 2021 to June 30, 2022. Merck will provide 13 standard adult vaccines including hepatitis A, hepatitis B, pneumococcal polysaccharide, tetanus/diphtheria toxoids, herpes zoster, measles/mumps/rubella, meningococcal conjugate, human papillomavirus, and varicella. Delivery must be within 15 business days to locations directed by the CDC throughout the United States to support state health departments and large city immunization programs.
The original solicitation sought contracts to purchase the 13 adult vaccines in minimum quantities for the CDC's National Center for Immunization and Respiratory Diseases. The vaccines will be used to support adult immunization programs as provided under Section 317(j) of the Public Health Service Act. No set-aside was used. Proposals were due by April 19, 2021 for contracts running from July 1, 2021 through June 30, 2022. The purpose of the contracts is to provide CDC awardees with access to the stated vaccines to support public health efforts to expand adult immunization rates across the country.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | -$286,568 | |
| Novation Agreement | $0 | |
| Funding Only Action | $3,898,675 | |
| Funding Only Action | $908,549 | |
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Funding Only Action | $3,823,471 | |
| Funding Only Action | $616,995 | |
| Funding Only Action | $5,351,188 | |
| Original award | $3,768,175 |
Quick answers
Who was awarded contract 75D30121D11354?
75D30121D11354 was awarded to Merck Sharp & Dohme LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on June 25, 2021.
How much is contract 75D30121D11354 worth?
75D30121D11354's own ceiling is $83,485,760. A single order can be worth up to $83,485,760.
Who can order from contract 75D30121D11354?
75D30121D11354 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75D30121D11354 competed?
The extent of competition for 75D30121D11354 was full and open competition. The government received 6 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV